For the Inventor, By the Inventor

Enter assignee name

Tokyo Metropolitan Organization for Medical Research

USPTO Granted Patents = 11

EPO Patents = 9

Forward Citations = 43

Loading Chart...

Loading Chart...

38 inventors (with patents filed for the assignee):

Takaji Wakita (5 out of 24 patents)

Tomoko Date (4 out of 11 patents)

Takanobu Kato (4 out of 10 patents)

4. Hitoshi Sakuraba (3 out of 7 patents)

5. Michiko Miyamoto (3 out of 6 patents)

6. Youichi Tajima (2 out of 6 patents)

7. Seiichi Aikawa (2 out of 6 patents)

8. Fumiko Aikawa (2 out of 6 patents)

9. Mai Ito (2 out of 4 patents)

10. Kazuo Kobayashi (1 out of 46 patents)

11. Koji Yamaguchi (1 out of 3 patents)

12. Kazutaka Ikeda (1 out of 22 patents)

13. Daisuke Nishizawa (1 out of 2 patents)

14. Yasunori Chiba (1 out of 22 patents)

15. Jun-ichi Tanabe (1 out of 6 patents)

11 patents: Sort by Forward Citations

1. 9134313 - Method of detecting colorectal cancer of stages 0 to I (2015-09-15),

2. 8604179 - Nucleic acid comprising chimeric gene derived from hepatitis C virus (2013-12-10),

3. 8323640 - Highly functional enzyme having α-galactosidase activity (2012-12-04),

4. 8022197 - Nucleic acid and gene derived from novel HCV strain and replicon-replicating cell using said gene (2011-09-20),

5. 7935676 - Nucleic acid construct containing a nucleic acid derived from the genome of hepatitis C virus (HCV) of genotype 2A, and a cell having such nucleic acid construct introduced therein (2011-05-03),

6. 7935336 - Highly functional enzyme having α-galactosidase activity (2011-05-03),

7. 7858313 - Method of evaluating drug sensitivity by analyzing GIRK channel genes (2010-12-28),

8. 7790448 - Nucleic acid and gene derived from novel HCV strain and replicon-replicating cell using said gene (2010-09-07),

9. 7659103 - Nucleic acid construct containing fulllength genome of human hepatitis C virus, recombinant fulllength virus genome-replicating cells having the nucleic acid construct transferred thereinto and method of producing hepatitis C virus Particle (2010-02-09),

10. 7579166 - Glycoprotein and process for producing the same (2009-08-25),

11. 7227052 - GFP expression vector localized in mitochondria (2007-06-05),

The Tokyo Metropolitan Organization for Medical Research (TOMOR) is a leading medical research institution in Tokyo, Japan. TOMOR conducts cutting-edge research in various fields such as oncology, neurology, and infectious diseases to improve healthcare outcomes. With state-of-the-art facilities and a team of skilled researchers, TOMOR is dedicated to advancing medical knowledge and finding innovative solutions to complex health challenges.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

11 Patents

#1,588 in Tokyo

#4,042 in Japan

#50,255 in the World

Tokyo Metropolitan Organization for Medical Research

Forward Citations = 43

38 inventors:

Takaji Wakita (5 out of 24 patents)

Tomoko Date (4 out of 11 patents)

Takanobu Kato (4 out of 10 patents)

4. Hitoshi Sakuraba (3 out of 7 patents)

5. Michiko Miyamoto (3 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…